BIRC5 and craniopharyngioma: Furthermore, it was identified that survivin protein expression levels are higher in recurrent craniopharyngioma cases compared with non-recurrent cases, indicating that higher survivin expression levels may inhibit apoptosis and promote tumor recurrence.